Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RGT-018 |
Trade Name | |
Synonyms | RGT 018|RGT018 |
Drug Descriptions |
RGT-018 selectively inhibits SOS1, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 39087485). |
DrugClasses | SOS1 Inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abemaciclib + RGT-018 | Abemaciclib RGT-018 | 0 | 0 |
Adagrasib + RGT-018 | Adagrasib RGT-018 | 0 | 0 |
Afatinib + RGT-018 | Afatinib RGT-018 | 0 | 0 |
Cetuximab + RGT-018 | Cetuximab RGT-018 | 0 | 0 |
Cobimetinib + RGT-018 | Cobimetinib RGT-018 | 0 | 0 |
Gefitinib + RGT-018 | Gefitinib RGT-018 | 0 | 0 |
MRTX-1133 + RGT-018 | MRTX-1133 RGT-018 | 0 | 0 |
RGT-018 | RGT-018 | 1 | 0 |
RGT-018 + Sotorasib | RGT-018 Sotorasib | 0 | 0 |
RGT-018 + Trametinib | RGT-018 Trametinib | 0 | 0 |